Cutler Group’s Tiziana Life Sciences TLSA Stock Holding History

Cutler Group’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,200	Closed	-$1K	–	6345
2021 Q1	$1K	Buy	+2,200	New	+$7.3K	﹤0.01%	5376

Other funds holding TLSA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Cutler Group's TLSA Position: Q1 2024 in Review

Cutler Group sold out of Tiziana Life Sciences (TLSA) in Q1 2024, closing a stake of 1,000 shares.

Cutler Group first reported a position in TLSA in Q3 2020 and held it in 13 quarters. The position peaked at $1K in Q1 2023. 20 funds tracked by Wall St. Rank hold TLSA as of Q1 2024.

Cutler Group reported no remaining Tiziana Life Sciences position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 1,000 Tiziana Life Sciences shares in Q1 2024.
Cutler Group first reported a position in Tiziana Life Sciences in Q3 2020 and held it in 13 quarters.
Cutler Group's Tiziana Life Sciences position peaked at $1K in Q1 2023.
20 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.